Delisting riskPopularity #4,665
Apimeds Pharmaceuticals US (APUS)
Developing a bee-venom knee-osteoarthritis therapy and Bitcoin-treasury infrastructure.
$1.97
vs last close+0.12 (+6.49%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 2.82% | 42.6K shares | |
|---|---|---|---|
| 7 holders · as of Jun 30, 2026 | |||
| Other | 97.18% | 1.47M shares | |
| remainder | |||
1.51M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
7 holders · 426.3K shares · 2 new positions · 3 increased · 2 reduced · 1 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Hemenway Trust Co LLC | 274.0K | 18.16% | 0 | Aug 11, 2026 |
| Vanguard Capital Management LLC | 63.7K | 4.22% | −32.3K | Aug 13, 2026 |
| Geode Capital Management, LLC | 35.1K | 2.33% | −4.9K | Aug 12, 2026 |
| Vanguard Fiduciary Trust Co | 24.0K | 1.59% | 0 | Aug 13, 2026 |
| Jane Street Group, LLC | 16.0K | 1.06% | +16.0K | Aug 14, 2026 |
| UBS Group AG | 11.8K | 0.78% | +7.6K | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 1.7K | 0.11% | +1.7K | Aug 11, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Apimeds Inc.incl. Inscobee Inc. | 34.30% | 13D | May 7, 2026 | |
| Ayrton Capital LLC | 9.99% | 13G | Feb 11, 2026 |
Form 4
Latest trades
Nothing filed in the last 12 months.
House and Senate disclosures
Not reported.